Abstract:Objective To compare the effects of blood pressure control and the expense of antihypertensive drugs among patients using different treatment methods .Methods Between September to December in 2013, we enrolled 79 patients who were under the administration of community follow -up management on hypertension but received treatment and obtained antihypertensive drugs in the secondary or tertiary hospitals as non -community treatment group.By 1:1 match in the aspects of gender, age, BMI, education level, course of disease, risk stratification, working condition and medical expense , we included 79 patients who were under the administration of community follow -up management on hypertension and received treatment and obtained antihypertensive drugs in community health service settings as community treatment group .PHQ-9 was adopted to conduct assessment on these patients .Patients′awareness rate of risk factors for hypertension , compliance to drug administration and blood pressure control rate were investigated as the indexes of blood pressure control effect ; the number of visits to doctors, the total medical expense for hypertension treatment , the expense covered by medical insurance , self -paid expense, monthly expense for antihypertensive drugs , expense per time and categories of antihypertensive drugs in the past 6 months were collected.Results The two groups were not significantly different in PHQ-9 score ( P>0.05) .The two groups were not significantly different in patients′awareness rate of risk factors for hypertension ( P>0.05 ) , and the two groups were significantly different in the rate of compliance to drug administration and blood pressure control rate (P<0.05) .The two groups were not significantly different in the number of visits to doctors (P>0.05), and the two group were significantly different in the total medical expenses for hypertension treatment , the expense covered by medical insurance , self -paid expense , monthly expense for antihypertensive drugs and expense per time ( P<0.05 ) .The two groups were significantly different in the usage rates of calcium antagonists and Zhenjujiangya tablets ( P <0.05 ) , and the two groups were not significantly different in diuretics, β-receptor blocker, angiotensin converting enzyme inhibitor , angiotensinⅡreceptor blocker and compound reserpine ( P>0.05 ) .Conclusion Patients who are treated in community health service settings have superior compliance to drug administration, higher blood pressure control rate and lower medical expense than patients who are treated in non -community medical settings.

The Effect of Measuring Times on the Blood Pressure Values with Electronic Automatic Blood Pressure Monitor

Efficacy and Safety of the Compound of Candesartan Cilexetial and Hydrochlorothiazide in Patients with Essential Hypertension

Effects of Atenolol and Diltiazem-Sr on Quality of Life in the Hypertensive Patients

[A Randomized, Double-Blind, Double-Dummy Study Comparing a Fixed Dose Combination of Telmisartan 80 Mg Plus Hydrochlorothiazide 12.5 Mg to Telmisartan 80 Mg in Chinese Hypertensive Patients Who Failed to Respond Adequately to Telmisartan 80 Mg].

Efficacy of telmisartan/hydrochlorothiazide in patients with mild to moderate primary hypertension using ambulatory blood pressure monitoring

Short-term therapeutic effect and safety of combined benazepril and lercanidipine for mild-moderate hypertension

Antihypertensive Effects of Irbesartan Single and Combined Treatments on 60 Patients with Mild to Moderate Essential Hypertension

OS 07-04 HOME BLOOD PRESSURE MONITORING IMPROVED SAFETY IN PATIENTS WITH SEVERE HYPERTENSION

[Evaluation on the Effect of Benazepril for Hypertension Through Postmarketing Surveillance].

Effects and Expense of Blood Pressure Control on Hypertensive Patients Using Different Treatment Methods: A Comparative Study

Efficacy and Safety of Olmesartan Medoxomil-Amlodipine Besylate Tablet in Chinese Patients with Essential Hypertension: A Prospective, Single-Arm, Multi-Center, Real-World Study

Comparison of two single-pill dual combination antihypertensive therapies in Chinese patients: a randomized, controlled trial

Postmarketing surveillance study of benazepril in chinese patients with hypertension: An open-label, experimental, epidemiologic study

The Effects of Olmesartan on Ambulatory Blood Pressures and Blood Pressure Variability in Patients with Mild to Moderate Essential Hypertension

Postmarketing Surveillance on Benazepril

The Influence of Combined Bisorpolol/hydrochlorothiazide on Morning Blood Pressure Surge in Mild to Moderate Es- sential Hypertension

The Antihypertensive Efficacy and Safety of Benazepril in Chinese Population: a Meta-Analysis of Randomized Controlled Trials

Meta-analysis of the Efficacy and Safety of Benazepril vs. Captopril in the Treatment of Primary Hypertension

COMPARATIVE EFFECTIVENESS OF FREE AND FIXED COMBINED ANTIHYPERTENSIVE THERAPY IN ACHIEVING TARGET BLOOD PRESSURE VALUES IN UNCONTROLLED ARTERIAL HYPERTENSION

Clinical Observation on efficacy and safety of Telmisartan hydrochlorothiazide and Telmisartan in patients with Mild to Moderate Essential hypertension